B Riley

A little more than a year after its initial public offering, Tocagen Inc (NASDAQ: TOCA) has traded down 26 percent, but experts are decidedly bullish on the company’s prospects and potential valuation. The Rating B Riley analyst Madhu Kumar initiated coverage on Tocagen with a Buy rating...

Carvana Co (NYSE: CVNA) is up 160 percent year-over-year, and one seller is signing on for the continuing momentum.  The Rating B. Riley FBR analyst Sameet Sinha upgraded Carvana from Sell to Buy and increased the price target from $20 to $38. The Thesis Sinha identified particular “...

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) continued to decline after Pfizer Inc. (NYSE: PFE) reported its transthyretin stabilizer Vyndaqel met primary Phase 3 endpoints Thursday. However, B Riley FBR considers the ostensible competitor’s victory a positive for Alnylam. The Rating...

Lululemon Athletica inc. (NASDAQ: LULU) were up more than 9 percent at the close Wednesday following a fourth-quarter earnings beat that saw comps up a remarkable 12 percent. The athletic apparel maker reported a Q4 adjusted EPS of $1.33 against a $1.27 estimate, sales of $928.8 million versus the...

Nike Inc (NYSE: NKE) is set to report earnings after the close on Thursday, March 22, one week after competitor adidas AG (ADR) (OTC: ADDYY) announced another quarter of double-digit growth in North America. B Riley Stays Neutral  With Nike's promotional activity remaining high in North...

Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) announced Tuesday that the U.S. Food and Drug Administration accepted a New Drug Application for eravacycline, an antibiotic for complicated intra-abdominal infection, for priority review. Traders initially reacted positively, and so did analysts. The...

A comeback in denim could fuel significant upside for Guess?, Inc. (NYSE: GES) in coming years, a B Riley FBR analyst said in a Monday upgrade note.  The Analyst Susan Anderson of B Riley upgraded Guess from Neutral to Buy rating and with a $20 price target.  The Thesis When...

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH)’s kinase switch control platform has largely gone unnoticed on the Street. The nascent portfolio caught an analyst's attention this week.  The Rating B Riley analyst Madhu Kumar initiated coverage on Deciphera with a Buy rating and $43...

The cloud segment saw a major shakeup this week after salesforce.com, inc. (NYSE: CRM) and Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) confirmed a new partnership. As part of the agreement, Google's office software suite will be integrated into Salesforce's core platform, while Google...

Shares of AMC Entertainment Holdings Inc (NYSE: AMC) hit a new 52-week low of $11.25 Tuesday morning, but quickly rebounded into positive territory. Some of Wall Street's top analysts were encouraged by the company's third-quarter earnings report and defended against a concerning guidance...